Comments
Loading...
Parnell Pharmaceuticals Analyst Ratings and Price Targets | OTC:PARNF | Benzinga
Parnell Pharmaceuticals Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Parnell Pharmaceuticals Corp from these most-recent analyst ratings.
Analyst Ratings for Parnell Pharmaceuticals
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Parnell Pharmaceuticals (PARNF) stock?
There is no price target for Parnell Pharmaceuticals
What is the most recent analyst rating for Parnell Pharmaceuticals (PARNF)?
There is no analyst for Parnell Pharmaceuticals
When was the last upgrade for Parnell Pharmaceuticals (PARNF)?
There is no last upgrade for Parnell Pharmaceuticals
When was the last downgrade for Parnell Pharmaceuticals (PARNF)?
There is no last downgrade for Parnell Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Parnell Pharmaceuticals (PARNF)?
There is no next analyst rating for Parnell Pharmaceuticals.
Is the Analyst Rating Parnell Pharmaceuticals (PARNF) correct?
There is no next analyst rating for Parnell Pharmaceuticals.
Browse analyst ratings and price targets on all stocks.